Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic amoxicillin prophylaxis in implant therapy with simultaneous guided bone regeneration
2013-001811-56Phase 4Completed
- Sponsor
- Universitätsklinik für Zahn-, Mund- und Kieferheilkunde, Med Uni Graz
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin in Alveolar bone atrophy (ABL) and partial edentulism (2 arms), sponsored by Universitätsklinik für Zahn-, Mund- und Kieferheilkunde, Med Uni Graz. Primary endpoints: Risk of antibiotic resistance and drug side effects in the test group, Risk of postoperative infection and complications in the control group and 1 more. Started Sep 2014; status: completed.
02
Drugs
amoxicillin
03
Conditions
Alveolar bone atrophy (ABL)partial edentulism
Beyond the preview
Go deeper on 2013-001811-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001811-56.